NPS Pharmaceuticals (NPSP) is a clinical-stage biopharmaceutical company. NPS Pharma is focused on the development of orphan products for patients with rare gastrointestinal and endocrine disorders and high unmet medical needs. This stock is trading up 7% at $7.26 in recent trading.
Today's Range: $6.77-$7.2752-Week Range: $4.35-$10.33 Volume: 755,000 Three-Month Average Volume: 672,986 >>5 Stocks Under $10 Poised for Breakouts From a technical perspective, NPSP is soaring here back above its 50-day moving average of $7.18 with above average volume. This move is now setting NPSP up for a much larger trend higher. Traders should continue to look for long-biased trades as long as NPSP is trending above its 50-day with strong upside volume flows. I would consider any upside volume day that registers near or above 672,986 shares as bullish. If we continue to see that trend, then look for NPSP to re-test $7.60 and then possibly fill a previous gap back towards $8 to $8.35. This stock has some major overhead resistance at $8.35 to $8.48, so if it were to take those levels out with volume it would be very bullish in the near-term. On the flipside, I would avoid this stock or look for short-biased trades if it fails to get into that gap, or if it drops back below its 50-day with heavy volume.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV